Postmenopausal Estrogen/Progestin Interventions (PEPI)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1987

Study Completion Date

October 31, 2000

Conditions
Bone DiseasesCardiovascular DiseasesCoronary DiseaseDiabetes MellitusHeart DiseasesHypercholesterolemiaHypertensionMyocardial IschemiaOsteoporosisThrombosisPostmenopause
Interventions
DRUG

estrogens, conjugated

DRUG

medroxyprogesterone

DRUG

progesterone

DRUG

estrogen replacement therapy

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000466 - Postmenopausal Estrogen/Progestin Interventions (PEPI) | Biotech Hunter | Biotech Hunter